Biobadaser 2.0: analysis and trends in 2009 Miguel Ángel Descalzo, Loreto Carmona

Objectives and methodology of BIOBADASER phase III Carlos Sanchez-Piedra, M. Victoria Hernández Miguel, Javier Manero, Rosa Roselló, Jesús Tomás Sánchez-Costa, Carlos Rodríguez-Lozano, Cristina Campos, Eduardo Cuende, Jesús Carlos Fernández-Lopez, Sagrario Bustabad, Raquel Martín Domenech, Eva Pérez-Pampín, Javier del Pino-Montes, Ana Milena Millan-Arciniegas, Federico Díaz-González, Juan Jesús Gómez-Reino

Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies Paloma de Abreu, Gabriela Ávila-Pedretti, Zoilo Morel, María Isabel Acosta, Sonia Cabrera-Villalba, Patricia Melgarejo, Marcos Franco, Pedro Delgadillo, Lourdes Román, Juan Gabriel Elizaur, Ernesto Paredes, Darwin Octavio Cordobilla, Daniel Palleiro, Miguel Albanese, Julio Mazzoleni